TRIFARMA SPA

Overview

TRIFARMA SPA is an active pharmaceutical ingredient (API) supplier with 20 active FDA Type II Drug Master Files, covering CLINDAMYCIN PHOSPHATE USP; CLOCORTOLONE PIVALATE; EPINASTINE HYDROCHLORIDE; FLUPHENAZINE DECANOATE; FLUPHENAZINE HCL; FOSCARNET SODIUM.

API / Drug Master Files

TRIFARMA SPA holds 20 active (26 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HYDROCORTISONE VALERATEActive2018-12-19
• CLOCORTOLONE PIVALATEActive2015-04-29
• FLUPHENAZINE DECANOATEActive2013-12-23
• ZOLEDRONIC ACIDActive2013-04-24
• GANCICLOVIR, USPActive2010-04-16
• EPINASTINE HYDROCHLORIDEActive2008-08-01
• TESTOSTERONE CYPIONATE USPActive2007-11-21
• PROCHLORPERAZINE BASEActive2006-06-02
• FOSCARNET SODIUMActive2006-01-04
• HALOBETASOL PROPIONATEActive2005-08-04
• OXANDROLONE USPActive2005-01-05
• TRANYLCYPROMINE SULFATEActive2003-02-27
• PROCHLORPERAZINE EDISYLATE USPActive2002-07-19
• CLINDAMYCIN PHOSPHATE USPActive1998-04-02
• MINOXIDIL USPActive1985-08-19

Showing 15 of 26 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TRIFARMA SPA in our records. PharmaTek screens the full directory against live FDA enforcement data.